The core activity of Creoptix is the development and manufacturing of bioanalytical instruments and technologies for molecular interaction analysis, particularly for drug discovery and life sciences. The instruments and technologies enable researchers to analyze biological interactions in real-time and investigate the binding kinetics of molecules. The company's products and services include, among others, WAVE systems, WAVE chips, GCI technology, microfluidics, and associated software.